118 related articles for article (PubMed ID: 36651368)
1. Relaxin inhibits
Xu J; Wan S; Chen W; Zhang Y; Ji Z
Acta Pharm; 2022 Dec; 72(4):575-585. PubMed ID: 36651368
[No Abstract] [Full Text] [Related]
2. Camptothecin Enhances Cell Death Induced by (177)Lu-EDTMP in Osteosarcoma Cells.
Kumar C; Vats K; Lohar SP; Korde A; Samuel G
Cancer Biother Radiopharm; 2014 Oct; 29(8):317-22. PubMed ID: 25226352
[TBL] [Abstract][Full Text] [Related]
3. Cellular toxicity and apoptosis studies in osteocarcinoma cells, a comparison of 177Lu-EDTMP and Lu-EDTMP.
Kumar C; Korde A; Kumari KV; Das T; Samuel G
Curr Radiopharm; 2013 Sep; 6(3):146-51. PubMed ID: 23895775
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of 177Lu-EDTMP in bone metastatic pain palliation in breast cancer and hormone refractory prostate cancer: a phase II study.
Yuan J; Liu C; Liu X; Wang Y; Kuai D; Zhang G; Zaknun JJ
Clin Nucl Med; 2013 Feb; 38(2):88-92. PubMed ID: 23334120
[TBL] [Abstract][Full Text] [Related]
5. 153Sm-EDTMP and 177Lu-EDTMP are equally safe and effective in pain palliation from skeletal metastases.
Taheri M; Azizmohammadi Z; Ansari M; Dadkhah P; Dehghan K; Valizadeh R; Assadi M
Nuklearmedizin; 2018 Sep; 57(5):174-180. PubMed ID: 30267399
[TBL] [Abstract][Full Text] [Related]
6. Protective Effects of Relaxin 2 (RLXH2) against Hypoxia-Induced Oxidative Damage and Cell Death via Activation of The Nrf2/HO-1 Signalling Pathway in Gastric Cancer Cells.
Wang L; Zhou Y; Lin H; Hou K
Cell J; 2023 Sep; 25(9):625-632. PubMed ID: 37718765
[TBL] [Abstract][Full Text] [Related]
7. Relaxin protects cardiomyocytes against hypoxia-induced damage in in-vitro conditions: Involvement of Nrf2/HO-1 signaling pathway.
Waza AA; Hamid Z; Bhat SA; Shah NUD; Bhat M; Ganai B
Life Sci; 2018 Nov; 213():25-31. PubMed ID: 30176248
[TBL] [Abstract][Full Text] [Related]
8. ¹⁷⁷Lu-EDTMP for treatment of bone pain in patients with disseminated skeletal metastases.
Shinto AS; Shibu D; Kamaleshwaran KK; Das T; Chakraborty S; Banerjee S; Thirumalaisamy P; Das P; Veersekar G
J Nucl Med Technol; 2014 Mar; 42(1):55-61. PubMed ID: 24503346
[TBL] [Abstract][Full Text] [Related]
9. Comparative studies on the potential use of
Zakaly HMH; Mostafa MYA; Deryabina D; Zhukovsky M
Int J Radiat Biol; 2020 Jun; 96(6):779-789. PubMed ID: 32043915
[No Abstract] [Full Text] [Related]
10.
Askari E; Harsini S; Vahidfar N; Divband G; Sadeghi R
Cancer Biother Radiopharm; 2021 Jun; 36(5):383-390. PubMed ID: 33259726
[No Abstract] [Full Text] [Related]
11. Formulation, preclinical evaluation, and preliminary clinical investigation of an in-house freeze-dried EDTMP kit suitable for the preparation of 177Lu-EDTMP.
Das T; Sarma HD; Shinto A; Kamaleshwaran KK; Banerjee S
Cancer Biother Radiopharm; 2014 Dec; 29(10):412-21. PubMed ID: 25409337
[TBL] [Abstract][Full Text] [Related]
12.
Kumar C; Sharma R; Das T; Korde A; Sarma H; Banerjee S; Dash A
J Labelled Comp Radiopharm; 2018 Sep; 61(11):837-846. PubMed ID: 29923620
[TBL] [Abstract][Full Text] [Related]
13. Multispecies animal investigation on biodistribution, pharmacokinetics and toxicity of 177Lu-EDTMP, a potential bone pain palliation agent.
Máthé D; Balogh L; Polyák A; Király R; Márián T; Pawlak D; Zaknun JJ; Pillai MR; Jánoki GA
Nucl Med Biol; 2010 Feb; 37(2):215-26. PubMed ID: 20152721
[TBL] [Abstract][Full Text] [Related]
14. Theabrownin triggers DNA damage to suppress human osteosarcoma U2OS cells by activating p53 signalling pathway.
Jin W; Zhou L; Yan B; Yan L; Liu F; Tong P; Yu W; Dong X; Xie L; Zhang J; Xu Y; Li C; Yuan Q; Shan L; Efferth T
J Cell Mol Med; 2018 Sep; 22(9):4423-4436. PubMed ID: 29993186
[TBL] [Abstract][Full Text] [Related]
15. Relaxin promotes in vitro tumour growth, invasion and angiogenesis of human Saos-2 osteosarcoma cells by AKT/VEGF pathway.
Ma JF; Von Kalle M; Plautz Q; -M Xu F; Singh L; Wang L
Eur Rev Med Pharmacol Sci; 2013 May; 17(10):1345-50. PubMed ID: 23740448
[TBL] [Abstract][Full Text] [Related]
16. Timing and optimized acquisition parameters for the whole-body imaging of ¹⁷⁷Lu-EDTMP toward performing bone pain palliation treatment.
Liu C; Brašić JR; Liu X; Li H; Xiang X; Luo Z; Wang Y; Kuai D; Zhang G; Zaknun JJ
Nucl Med Commun; 2012 Jan; 33(1):90-6. PubMed ID: 22001721
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and Ready to Use Kit Formulation of EDTMP for the Preparation of 177Lu-EDTMP as a Bone Palliation Radiopharmaceutical.
Mercanoglu G; Zilbeyaz K; Arslan N
Curr Radiopharm; 2023; 16(1):38-43. PubMed ID: 35899954
[TBL] [Abstract][Full Text] [Related]
18. Hematoporphyrin monomethyl ether-mediated photodynamic therapy selectively kills sarcomas by inducing apoptosis.
Zeng H; Sun M; Zhou C; Yin F; Wang Z; Hua Y; Cai Z
PLoS One; 2013; 8(10):e77727. PubMed ID: 24204937
[TBL] [Abstract][Full Text] [Related]
19. Comparative Therapeutic Efficacy of
Sharma S; Singh B; Koul A; Mittal BR
Front Med (Lausanne); 2017; 4():46. PubMed ID: 28507988
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
